AZD 4320 is a potent pyrazolopyrimidine derivative designed to act as an oral anticancer agent, primarily investigated for its mechanism as a DNA alkylating agent that targets the O6-guanine site to inhibit… Read more
AZD 4320 is a potent pyrazolopyrimidine derivative designed to act as an oral anticancer agent, primarily investigated for its mechanism as a DNA alkylating agent that targets the O6-guanine site to inhibit replication and induce cell death in solid tumors such as colorectal cancer. Laboratories working with this compound require high-quality analytical standards to ensure the accuracy and reliability of their research. This category includes the parent compound and its stable isotope labelled versions, such as AZD 4320-d4. Researchers utilize these reference standards for critical analytical procedures, including impurity profiling, method validation, and quantitative assessment using techniques like liquid chromatography-mass spectrometry. By employing deuterated internal standards, scientists can achieve precise quantification during complex stability studies and quality control assessments, facilitating the rigorous monitoring of drug purity and metabolic pathways during pharmaceutical development.